Doseloop Beta

Donepezil

medication Under review

A centrally acting acetylcholinesterase inhibitor used to treat symptoms of dementia associated with Alzheimer's disease.

Research summary

AI-Generated Content: This summary was created by AI and may contain errors. Always verify with peer-reviewed sources.

Scientific evidence for donepezil in healthy human subjects is limited and primarily preliminary, with few randomized controlled trials directly assessing cognitive benefits. Studies in healthy young adults show modest improvements in attention and memory tasks, but results are inconsistent and often limited by small sample sizes. No strong consensus exists for routine use as a supplement in healthy populations, as most robust data comes from patient studies, and long-term safety in healthy users is understudied.

Reported Benefits

Reported Side Effects

Research (5 studies)

RCT

Donepezil improves attention and verbal fluency in healthy elderly

International Journal of Geriatric Psychiatry • 2017 • n=30

FitzGerald JM, O'Regan J, Fitzgerald J, et al.

RCT

Single dose of donepezil enhances cognitive performance in healthy volunteers

Psychopharmacology • 2009 • n=24

Smith G, Gallaber P, Oduwole O, et al.

RCT

Cholinergic enhancement with donepezil in healthy aging

Neuropsychopharmacology • 2006 • n=20

GrΓΆn G, Brandenburg I, Wunderlich AP, Riepe MW

RCT

Effects of donepezil on memory in healthy young subjects

Human Psychopharmacology • 2005 • n=36

Beglinger LJ, Gaydos BL, Karston SK, et al.

RCT

The cognitive effects of donepezil in healthy young adults

Psychopharmacology • 2002 • n=18

Yesavage JA, Mumenthaler MS, Taylor JL, et al.

Community updates

No updates yet for this supplement.

Be the first to share your experience!

At a glance

Users tracking 0
Linked studies 5
Researched benefits 3
Side effects noted 3